Core Viewpoint - ImmuCell Corporation is set to report its unaudited financial results for the quarter and year ended December 31, 2025, on March 4, 2026, with a conference call scheduled for the following morning to discuss these results [1][2][3]. Financial Reporting - The company anticipates no changes to the preliminary sales results disclosed on January 8, 2026, for the quarter and year ended December 31, 2025 [3]. - ImmuCell plans to file its Annual Report on Form 10-K on or before March 31, 2026 [3]. Company Overview - ImmuCell Corporation focuses on developing, manufacturing, and marketing products that enhance cattle health and productivity, including its product First Defense, which provides Immediate Immunity™ to newborn dairy and beef calves [4].

Company Overview - VivoPower International PLC is a B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications [2] - Founded in 2014 and listed on Nasdaq since 2016, VivoPower operates in regions including the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia [2] - The company's mission is to be a trusted partner for sovereign nations in developing sustainable data center infrastructure, ensuring control over power, data, and national intelligence [2] Recent Developments - All board members of VivoPower have increased their shareholdings by a total of 2.65 million shares, with Executive Chairman Kevin Chin accounting for the majority of this increase [1] - Each director has filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) regarding their share purchases [1]

Core Viewpoint - Holley Performance Brands will release its fourth quarter and full year 2025 financial results on March 4, 2026, and will host a conference call to discuss these results [1][2]. Financial Results Announcement - The earnings release and presentation for the fourth quarter and full year 2025 will be available before the market opens on March 4, 2026 [2]. - A conference call and live webcast will take place at 8:30 am Eastern Time on the same day [2][4]. Conference Call Details - The call will be hosted by Holley Inc. President and CEO Matthew Stevenson and CFO Jesse Weaver [3]. - Dial-in numbers for the United States are provided, along with an access code for participants [4]. - A replay of the conference call will be available until March 11, 2026, with details on how to access it [4]. Company Overview - Holley Performance Brands specializes in high-performance products for automotive enthusiasts and manages a portfolio of iconic brands [5]. - The company focuses on four consumer verticals: Domestic Muscle, Modern Truck & Off-Road, Euro & Import, and Safety & Racing, which enhances its impact in the automotive aftermarket industry [5]. - Holley is recognized for its innovative approach and strategic acquisitions aimed at improving the enthusiast experience and driving growth [5].

Core Insights - Inspira Technologies has initiated a structured commercial evaluation of its FDA-cleared INSPIRA™ ART100 system at a leading U.S. academic medical center, expanding its presence in the Tier-1 U.S. hospital market [1][3] Company Overview - Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions [5] - The INSPIRA™ ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., serving as a foundation for the development of the next-generation INSPIRA ART500 system [5] - The company is also advancing the HYLA™ platform, a proprietary blood sensor offering continuous, non-invasive monitoring [5] Market Positioning - The deployment of the ART100 system is part of the company's U.S. commercial strategy, aiming to convert high-profile evaluations into a sustainable commercial pipeline [4] - The partnering institution is ranked among New York State's top 10 hospitals, indicating the ART100's alignment with the operational and clinical demands of top-tier U.S. healthcare providers [2][4]

Core Insights - Lakeland Industries, Inc. announced that its subsidiary California PPE has been selected to provide turnout gear maintenance and decontamination services for the Newport Beach Fire Department, highlighting the company's service quality and market position in the PPE sector [1][3]. Company Overview - Lakeland Fire + Safety is a global manufacturer of protective clothing and apparel, serving industries such as healthcare and first responders, and offers a comprehensive line of fire services and industrial protective clothing [4]. - California PPE is recognized as a leading and rapidly expanding UL-certified service provider in the California firefighting services market, focusing on advanced decontamination, repair, and inspection of firefighting PPE [2]. Strategic Positioning - The award to California PPE reflects the company's strategy to expand its recurring service offerings in North America, emphasizing the importance of verified, standards-based care and maintenance programs for firefighting gear [3]. - The scope of work includes maintenance and cleaning of turnout gear in compliance with NFPA 1850 requirements, ensuring documented inspection and care practices to support firefighter health and safety [3]. Market Demand - There is an increasing emphasis from fire departments on verified care and maintenance programs for turnout gear, indicating a growing market demand for such services [3].

Core Viewpoint - Aware, Inc. will hold a webcast on March 4, 2026, to discuss its financial results for Q4 and the fiscal year ending December 31, 2025 [1][2]. Company Overview - Aware, Inc. is a global leader in biometric identity and authentication solutions, providing the Awareness Platform that transforms biometric data into actionable intelligence [3]. - The platform is designed for mission-critical enterprise environments, offering intelligent, scalable architecture, real-time insights, and reliable security [3]. - Aware is headquartered in Burlington, Massachusetts [3].

Core Viewpoint - Bath & Body Works, Inc. plans to report its fourth quarter and fiscal 2025 financial results on March 4, 2026, before market open, followed by a conference call to discuss the results and provide a business update [1]. Group 1 - The conference call will take place at 8:30 a.m. ET and will feature CEO Daniel Heaf and CFO Eva Boratto [1]. - Supplemental materials related to the financial results will be available approximately 90 minutes before the conference call on the company's website [1]. - Investors and analysts can participate in the conference call by dialing specific domestic and international numbers [2]. Group 2 - A telephone replay of the conference call will be accessible after the live event, with specific access codes provided for domestic and international callers [2]. - The audio webcast of the conference call can be accessed on the company's website, with a replay available approximately three hours after the live call and archived for 90 days [3]. Group 3 - Bath & Body Works is a global leader in personal care and home fragrance, offering a variety of products including fine fragrance mist, body lotion, and 3-wick candles [4]. - The company operates 1,934 company-operated locations in the U.S. and Canada, along with 544 international franchised locations and an online storefront [4].

New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ: CISO) (“CISO Global” or the “Company”), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transiti ...

Core Viewpoint - Monument Mining Limited has announced positive results from its ongoing drilling program at the Buffalo Reef/Felda areas, which is part of the Selinsing Gold Mine expansion project in Malaysia. The results indicate significant gold mineralization and continuity between drill holes, supporting the potential increase in gold resources and extending the mine's life. Drilling Program Highlights - The company has received results from fifteen completed drill holes, with high gold assay results reported [3][4]. - Expansion drilling is currently targeting to increase gold resources and potentially extend the life of the Selinsing Gold Mine, with plans to increase the number of drill rigs from four to nine [2][10]. Significant Drill Results - Notable results include: - MBRDD614: 7.3m at 1.76g/t Au, including 3.0m at 3.35g/t Au [5]. - MBRDD618: 1.6m at 28g/t Au from 95.5m depth [6]. - MBRDD619: 5.7m at 1.72g/t Au, including 3.0m at 4.51g/t Au [7][29]. Expansion Drilling Program - The Buffalo Reef/Felda mine expansion drilling program is divided into Stage 1 and Stage 2, covering a total area of 115 acres, aimed at evaluating the potential to extend currently defined mineral resources [9][28]. - The program has successfully intersected multiple zones of gold mineralization, validating the expansion drilling strategy [10]. Future Plans - The company plans to continue its drilling efforts to further assess the potential of mineralization and will conduct geological interpretation and modeling to confirm structural and grade continuity [30][38]. - The Selinsing mine expansion drilling program will commence once the Buffalo Reef/Felda program concludes, with a focus on high-grade depth extensions and local extensions to modelled gold structures [50][51].

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest T ...